rs5751348

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_017436.7(A4GALT):​c.-188+3010G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.417 in 151,992 control chromosomes in the GnomAD database, including 15,230 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 15230 hom., cov: 32)

Consequence

A4GALT
NM_017436.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.75

Publications

20 publications found
Variant links:
Genes affected
A4GALT (HGNC:18149): (alpha 1,4-galactosyltransferase (P1PK blood group)) The protein encoded by this gene catalyzes the transfer of galactose to lactosylceramide to form globotriaosylceramide, which has been identified as the P(k) antigen of the P blood group system. This protein, a type II membrane protein found in the Golgi, is also required for the synthesis of the bacterial verotoxins receptor. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]
CYB5R3 (HGNC:2873): (cytochrome b5 reductase 3) This gene encodes cytochrome b5 reductase, which includes a membrane-bound form in somatic cells (anchored in the endoplasmic reticulum, mitochondrial and other membranes) and a soluble form in erythrocytes. The membrane-bound form exists mainly on the cytoplasmic side of the endoplasmic reticulum and functions in desaturation and elongation of fatty acids, in cholesterol biosynthesis, and in drug metabolism. The erythrocyte form is located in a soluble fraction of circulating erythrocytes and is involved in methemoglobin reduction. The membrane-bound form has both membrane-binding and catalytic domains, while the soluble form has only the catalytic domain. Alternate splicing results in multiple transcript variants. Mutations in this gene cause methemoglobinemias. [provided by RefSeq, Jan 2010]
CYB5R3 Gene-Disease associations (from GenCC):
  • methemoglobinemia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Illumina
  • methemoglobinemia due to deficiency of methemoglobin reductase
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hereditary methemoglobinemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.801 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
A4GALTNM_017436.7 linkc.-188+3010G>T intron_variant Intron 1 of 2 ENST00000642412.2 NP_059132.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
A4GALTENST00000642412.2 linkc.-188+3010G>T intron_variant Intron 1 of 2 NM_017436.7 ENSP00000494127.1

Frequencies

GnomAD3 genomes
AF:
0.418
AC:
63433
AN:
151874
Hom.:
15235
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.183
Gnomad AMI
AF:
0.415
Gnomad AMR
AF:
0.462
Gnomad ASJ
AF:
0.496
Gnomad EAS
AF:
0.823
Gnomad SAS
AF:
0.553
Gnomad FIN
AF:
0.526
Gnomad MID
AF:
0.525
Gnomad NFE
AF:
0.488
Gnomad OTH
AF:
0.455
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.417
AC:
63438
AN:
151992
Hom.:
15230
Cov.:
32
AF XY:
0.425
AC XY:
31534
AN XY:
74280
show subpopulations
African (AFR)
AF:
0.183
AC:
7576
AN:
41458
American (AMR)
AF:
0.462
AC:
7050
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.496
AC:
1721
AN:
3470
East Asian (EAS)
AF:
0.822
AC:
4248
AN:
5168
South Asian (SAS)
AF:
0.552
AC:
2663
AN:
4822
European-Finnish (FIN)
AF:
0.526
AC:
5550
AN:
10548
Middle Eastern (MID)
AF:
0.531
AC:
156
AN:
294
European-Non Finnish (NFE)
AF:
0.488
AC:
33131
AN:
67960
Other (OTH)
AF:
0.459
AC:
966
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1713
3425
5138
6850
8563
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
596
1192
1788
2384
2980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.467
Hom.:
9210
Bravo
AF:
0.401
Asia WGS
AF:
0.612
AC:
2129
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
6.8
DANN
Benign
0.47
PhyloP100
1.7

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5751348; hg19: chr22-43113793; API